三级扩张球囊导管市场 - 全球产业规模、份额、趋势、机会及预测（按类型、应用、最终用户、地区和竞争格局划分），2021-2031年

全球三级扩张球囊导管市场预计将从 2025 年的 8.2631 亿美元成长到 2031 年的 11.5368 亿美元，复合年增长率为 5.72%。

这些非顺应性介入器械对于支架植入术后的手术至关重要，可确保支架的最佳扩张并与血管壁牢固黏附。该领域的发展主要受冠状动脉疾病负担日益加重以及随之而来的复杂介入手术数量的增加所驱动，而这些手术需要精确的血管准备。欧洲心臟学会报告称，到2024年，高所得成员国每百万人中经皮冠状动脉介入治疗（PCI）的中位数为2330例，这凸显了推动器械应用的大量手术需求。此外，治疗钙化病变的临床需求也进一步推动了这项需求，因为这些专用导管所提供的特定高压性能对于此类病变至关重要。

然而，严格的监管标准和安全隐患，特别是高压充气过程中血管破裂的风险，阻碍了市场发展。这些问题需要进行大量的临床试验和漫长的核准流程，从而延缓了先进器械改进版本的商业化。因此，製造商面临更高的遵循成本和更长的器械安全证明流程，有效地减缓了增强型导管技术在全球市场的推广。

市场驱动因素

由于糖尿病和肥胖等文明病相关合併症与代谢紊乱和复杂的血管钙化密切相关，其发病率的上升是全球三级扩张球囊导管市场的主要驱动因素。糖尿病患者常出现硬化、钙化的斑块，这些斑块难以透过标准血管成形术处理，因此需要利用三级球囊的高压、非顺应性特性来确保支架扩张和闭塞。根据国际糖尿病联盟（IDF）于2025年4月发布的《糖尿病地图集》，全球约有5.89亿成年人将患有糖尿病，这一人口趋势正在显着扩大需要这些特殊血管预备工具的患者群体。

同时，全球心血管和周边血管疾病发病率的上升推动了介入手术量的持续成长，进而带动了对扩张后解决方案的需求。随着冠状动脉疾病负担的加重，复杂支架植入术的频率也随之增加，这需要精准的球囊优化以预防血栓症和血管再阻塞等併发症。这一趋势也体现在行业业绩中。例如，波士顿科学公司在2024年10月公布，其心血管业务净销售额达到27.3亿美元，显示市场对介入手术的需求强劲。同样，雅培公司在2024年10月发布的「2024年第三季业绩报告」中预测，其医疗设备销售额将达到47.5亿美元，凸显了其介入业务的广泛扩张，并推动了三级球囊等辅助器材的应用。

市场挑战

由于高压充气过程中存在血管破裂等安全风险，严格的监管要求成为三级扩张球囊导管市场扩张的主要障碍。由于这些器械必须使用极高的压力才能有效矫正钙化病变，监管机构要求进行严格的上市前临床试验，以确保器械的完整性。这些强制性的安全检验流程显着增加了研发成本，同时也延长了获得市场核准所需的时间。这套颈部有效地延缓了更新、更安全的导管技术的商业化进程，并阻碍了製造商快速抓住不断增长的临床需求。

因此，高准入门槛阻碍了快速创新，迫使企业调整策略重点。这往往导致在合规制度复杂的地区，产品上市延迟。近期有关监理负担的产业数据也印证了市场进入的下降趋势。根据欧洲医疗技术协会（MedTech Europe）预测，2024年，选择欧盟作为首发市场的大型医疗设备製造商比例将比前一年下降33%。这主要是由于医疗设备法规（MDR）对资源彙整要求。这些产品供应延迟直接阻碍了全球市场维持与手术量相符的稳定成长。

市场趋势

随着医疗系统将成本控制和营运效率置于优先地位，向门诊手术中心（ASC）的转变正在从根本上改变市场格局。这项转变的驱动力在于不断演变的报销体系，该体系鼓励在门诊进行週边血管和冠状动脉介入治疗，从而减少对资本密集型医院导管检查室的依赖。为此，製造商正在调整其策略，提供针对这些机构所需的简化当日出院通讯协定优化的球囊导管产品线。有利的监管政策变化也为此结构性转变提供了支持。例如，根据门诊手术中心协会（ASCA）2025年1月发布的公告，美国医疗保险和医疗补助服务中心（CMS）在2025年医疗保险最终规则中最终确定将门诊手术中心的支付费率提高2.9%。这项政策调整增强了将复杂血管手术转移到成本更低的门诊机构的经济可行性。

同时，人们也高度关注能够最大限度减少血管损伤的技术，从而开发出先进的球囊，以减少扩张过程中的缺血性併发症。灌注球囊和高顺应性材料等创新技术能够使球囊与血管壁长时间贴合，而不会完全阻断血流，这对于安全治疗复杂病变并降低血管撕裂风险至关重要。这项技术进步直接满足了临床对超越简单高压扩张、在确保有效支架植入的同时维持血管整体完整性的器械的需求。近期产业趋势也印证了这个先进介入产品组合的市场成功。根据波士顿科学公司于2025年2月发布的“2024年第四季度及全年财务业绩”，心血管业务净销售额增长了28.8%，这反映出新一代介入治疗方法和血管预备工具的快速普及。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球三级扩张球囊导管市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（硅胶球囊导管、聚乙烯球囊导管）
  • 依应用领域（心臟病、血管疾病、消化系统疾病、泌尿器官系统疾病、妇科疾病）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美三级扩张球囊导管市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲三级扩编球囊导管市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区三级扩张球囊导管市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲三级扩张球囊导管市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲三级扩张球囊导管市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球三级扩张球囊导管市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Boston Scientific Corp
• Cook Medical Inc
• Terumo Corporation
• CR Bard Inc
• Braun Melsungen AG
• Abbott Laboratories Inc
• Medtronic Plc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Tertiary Dilation Balloon Catheters Market is projected to expand from USD 826.31 Million in 2025 to USD 1153.68 Million by 2031, registering a CAGR of 5.72%. These non-compliant interventional devices are essential during post-stenting procedures to guarantee optimal stent expansion and adherence to vessel walls. Growth in this sector is fundamentally driven by the escalating burden of coronary artery disease and the concurrent rise in complex interventional procedures that require precise vessel preparation. According to the European Society of Cardiology, high-income member nations reported a median rate of 2,330 percutaneous coronary interventions per million people in 2024, highlighting the substantial procedural volume that fuels device adoption. This demand is further intensified by the clinical requirement to treat calcified lesions, which necessitates the specific high-pressure capabilities provided by these specialized catheters.

However, market progression is hindered by strict regulatory standards and safety concerns, particularly the risk of vessel rupture during high-pressure inflation. These issues necessitate exhaustive clinical trials and protracted approval phases, which postpone the commercial release of advanced device iterations. Consequently, manufacturers encounter increased compliance expenditures and extended timelines to demonstrate device safety, effectively slowing the introduction of enhanced catheter technologies into the global marketplace.

Market Driver

The increasing prevalence of lifestyle-related comorbidities, such as diabetes and obesity, serves as a primary engine for the Global Tertiary Dilation Balloon Catheters Market, largely due to the link between metabolic disorders and complex vascular calcification. Diabetic patients frequently present with hardened, calcified plaques that resist standard angioplasty, requiring the high-pressure, non-compliant features of tertiary balloons to ensure successful stent expansion and apposition. Data from the International Diabetes Federation's 'IDF Diabetes Atlas' in April 2025 indicates that approximately 589 million adults globally were living with diabetes, a demographic trend that significantly widens the patient pool necessitating these specialized vessel preparation tools.

Simultaneously, the rising global incidence of cardiovascular and peripheral vascular diseases is driving a sustained increase in interventional procedural volumes, thereby elevating the demand for post-dilation solutions. As the burden of coronary artery disease grows, the frequency of complex stent implantations increases, mandating precise balloon optimization to prevent complications like thrombosis and restenosis. This momentum is reflected in industry performance; for instance, Boston Scientific reported in October 2024 that its Cardiovascular business achieved $2.73 billion in net sales, indicating strong procedural demand. Similarly, Abbott's 'Third-Quarter 2024 Financial Results' in October 2024 showed Medical Devices sales reaching $4.75 billion, underscoring the broader expansion of the interventional sector which supports the adoption of ancillary devices like tertiary balloons.

Market Challenge

The rigorous regulatory landscape, driven by safety risks such as vessel rupture during high-pressure inflation, represents a critical obstacle to the expansion of the tertiary dilation balloon catheters market. Since these devices must employ extreme pressure to effectively modify calcified lesions, regulatory bodies mandate stringent pre-market clinical testing to ensure device integrity. These compulsory safety validation processes significantly inflate research and development costs while extending the timeline required to secure market approval. This bottleneck effectively delays the commercialization of newer, safer catheter technologies, preventing manufacturers from swiftly capitalizing on rising clinical demand.

Consequently, the high barrier to entry discourages rapid innovation and compels companies to adjust their strategic priorities, often delaying product introductions in regions with complex compliance frameworks. This reduction in market accessibility is supported by recent industry data regarding regulatory burdens. According to MedTech Europe, in 2024, the percentage of large medical device manufacturers choosing the European Union as their initial launch geography fell by 33% compared to prior years, largely due to the resource-intensive requirements of the Medical Device Regulation. Such delays in product availability directly impede the global market's ability to maintain a steady growth trajectory consistent with procedural volumes.

Market Trends

The migration of procedures toward Ambulatory Surgical Centers is fundamentally reshaping the market landscape as healthcare systems prioritize cost containment and operational efficiency. This shift is actively facilitated by evolving reimbursement frameworks that encourage the performance of peripheral and coronary interventions in outpatient settings, thereby reducing reliance on capital-intensive hospital catheterization labs. Manufacturers are consequently realigning their strategies to provide balloon catheter portfolios optimized for the streamlined, same-day discharge protocols required by these facilities. This structural transition is supported by favorable regulatory updates; for instance, according to the Ambulatory Surgery Center Association in January 2025, the Centers for Medicare & Medicaid Services finalized a 2.9% payment rate increase for ambulatory surgical centers in the '2025 Medicare Final Rule', a policy adjustment that reinforces the economic viability of moving complex vascular procedures to these lower-cost environments.

Concurrently, there is a decisive focus on technologies designed to minimize vessel trauma, driving the development of sophisticated balloons that reduce ischemic complications during inflation. Innovations such as perfusion balloons and advanced compliance materials allow for prolonged vessel wall apposition without completely obstructing blood flow, a critical capability for treating complex lesions safely while mitigating the risk of dissection. This technological evolution directly addresses the clinical demand for devices that ensure effective stent deployment while preserving overall vessel integrity, moving beyond simple high-pressure expansion. The market success of these advanced interventional portfolios is evident in recent industry performance; according to Boston Scientific's 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025, the Cardiovascular segment achieved a 28.8% reported increase in net sales, reflecting the accelerating adoption of next-generation interventional therapies and vessel preparation tools.

Key Market Players

• Boston Scientific Corp
• Cook Medical Inc
• Terumo Corporation
• CR Bard Inc
• Braun Melsungen AG
• Abbott Laboratories Inc
• Medtronic Plc

Report Scope

In this report, the Global Tertiary Dilation Balloon Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Tertiary Dilation Balloon Catheters Market, By Type

• Silicone Balloon Catheters
• Polyethylene Balloon Catheters

Tertiary Dilation Balloon Catheters Market, By Application

• Heart Disease
• Vascular Disease
• Digestive Tract Disease
• Urinary System Disease
• Gynaecological Disease

Tertiary Dilation Balloon Catheters Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Tertiary Dilation Balloon Catheters Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tertiary Dilation Balloon Catheters Market.

Available Customizations:

Global Tertiary Dilation Balloon Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Tertiary Dilation Balloon Catheters Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Silicone Balloon Catheters, Polyethylene Balloon Catheters)
  • 5.2.2. By Application (Heart Disease, Vascular Disease, Digestive Tract Disease, Urinary System Disease, Gynaecological Disease)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Tertiary Dilation Balloon Catheters Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tertiary Dilation Balloon Catheters Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Tertiary Dilation Balloon Catheters Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Tertiary Dilation Balloon Catheters Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Tertiary Dilation Balloon Catheters Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Tertiary Dilation Balloon Catheters Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Tertiary Dilation Balloon Catheters Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Tertiary Dilation Balloon Catheters Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Tertiary Dilation Balloon Catheters Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Tertiary Dilation Balloon Catheters Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Tertiary Dilation Balloon Catheters Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Tertiary Dilation Balloon Catheters Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Tertiary Dilation Balloon Catheters Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Tertiary Dilation Balloon Catheters Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Tertiary Dilation Balloon Catheters Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Tertiary Dilation Balloon Catheters Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Tertiary Dilation Balloon Catheters Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Tertiary Dilation Balloon Catheters Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Tertiary Dilation Balloon Catheters Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Tertiary Dilation Balloon Catheters Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Tertiary Dilation Balloon Catheters Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Tertiary Dilation Balloon Catheters Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Tertiary Dilation Balloon Catheters Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Tertiary Dilation Balloon Catheters Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Tertiary Dilation Balloon Catheters Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corp
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cook Medical Inc
• 15.3. Terumo Corporation
• 15.4. CR Bard Inc
• 15.5. Braun Melsungen AG
• 15.6. Abbott Laboratories Inc
• 15.7. Medtronic Plc

16. Strategic Recommendations

17. About Us & Disclaimer